Oncorus, Inc. is a lean early-stage biotechnology company developing a next-generation immunotherapy platform to treat cancer. Oncorus was founded MPM Managing Director Mitch Finer, a well-known biotechnology entrepreneur. Oncorus is a leader in corporate philanthropy, and has taken a pledge to donate a portion of product sales to fund promising cancer research and to support cancer care in the developing world.

G1 Therapeutics is a clinical-stage company developing novel cancer therapies. It is also advancing rintodestrant, a potential oral selective estrogen receptor degrader, or serd, for the treatment of er+ breast cancer. It is committed to improving the lives of those impacted by cancer. It is also executing a tumor-agnostic development program, with late-stage clinical trials ongoing in multiple tumor types.

Kanagawa Prefectural Hospital Organization provides children's medical, psychiatric, Cancer Centers, surgical, and other hospital services.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

AskAt, Inc. is a company headquartered in Nagoya, Japan, that develops pharmaceutical products. It was founded in 2013. AskAt, Inc. was acquired by AskAat, Inc. from RaQualia Pharma, Inc. on May 14, 2015.

Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC.

SENTAN Pharma, Inc. is a company headquartered in Fukuoka, Japan, that develops and supplies drugs and medical devices. It was founded in 2007.

Carcinotech Ltd. is a British company located in Edinburgh. The firm manufactures 3D printed mini tumors developed from patient-specific cancer stem cells, primary cells and established cell lines. It was founded in 2018 by Ishani Malhotra, she has been the CEO since the inception date.

Korea Institute of Radiological & Medical Sciences specializes in radiation technology, research, development, genomics, and radiotherapy.

Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan.

Tandem is a company that nurtures people with IT technology.